SUN PHARMA ADVANCED RESEARCH COMPANY
Back to Income Statement
|
SUN PHARMA ADVANCED RESEARCH COMPANY Last 5 Year Consolidated Net Profit History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | |
|---|---|---|---|---|
| Consolidated Net Profit | ₹-343 Cr | ₹-387 Cr | ₹-223 Cr | ₹-223 Cr |
What is the latest Consolidated Net Profit of SUN PHARMA ADVANCED RESEARCH COMPANY ?
| Year | Consolidated Net Profit |
|---|---|
| Mar2026 | ₹-343 Cr |
| Mar2025 | ₹-387 Cr |
| Mar2024 | ₹-223 Cr |
| Mar2023 | ₹-223 Cr |
How is Consolidated Net Profit of SUN PHARMA ADVANCED RESEARCH COMPANY Trending?
| Years | Consolidated Net Profit | % Change | |
|---|---|---|---|
| Mar2026 | ₹-343 Cr | Negative | |
| Mar2025 | ₹-387 Cr | Negative | |
| Mar2024 | ₹-223 Cr | Negative | |
| Mar2023 | ₹-223 Cr | - | |
Compare Consolidated Net Profit of peers of SUN PHARMA ADVANCED RESEARCH COMPANY
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SUN PHARMA ADVANCED RESEARCH COMPANY | ₹5,740.4 Cr | -0.8% | -15.3% | 39.7% | Stock Analytics | |
| PRIME FOCUS | ₹22,424.8 Cr | 5% | -9.3% | 64.1% | Stock Analytics | |
| SAGILITY | ₹19,661.6 Cr | -5.6% | -1.9% | -6% | Stock Analytics | |
| INTERNATIONAL GEMOLOGICAL INSTITUTE | ₹17,180.5 Cr | 3.2% | 22.7% | 20% | Stock Analytics | |
| SYNGENE INTERNATIONAL | ₹16,251.7 Cr | 11.9% | 9.3% | -39.7% | Stock Analytics | |
| INDEGENE | ₹14,164.4 Cr | -2.3% | -2.8% | 9.9% | Stock Analytics | |
SUN PHARMA ADVANCED RESEARCH COMPANY Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SUN PHARMA ADVANCED RESEARCH COMPANY | -0.8% |
-15.3% |
39.7% |
| SENSEX | 1.8% |
2.3% |
-11.9% |
You may also like the below Video Courses